tiprankstipranks
Legend Biotech Corporation (DE:9LB)
FRANKFURT:9LB
Holding DE:9LB?
Track your performance easily

Legend Biotech (9LB) Income Statement

2 Followers

Legend Biotech Income Statement

Last quarter (Q4 2023), Legend Biotech's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Legend Biotech's net income was $―. See Legend Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 53.35M$ 285.14M$ 117.00M$ 68.83M$ 75.00M$ 59.42M
Cost of Revenue
$ 16.94M$ 144.21M$ 65.36M---
Gross Profit
$ 36.41M$ 140.93M$ 51.64M$ 68.83M$ 75.00M$ 59.42M
Operating Expense
$ 231.15M$ 580.41M$ 507.26M$ -462.83M$ 259.52M$ 194.40M
Operating Income
$ -194.74M$ -470.70M$ -364.96M$ -373.04M$ -183.84M$ -134.98M
Net Non Operating Interest Income Expense
$ -2.64M$ -32.69M$ 2.61M$ -900.00K$ 2.93M$ -199.00K
Other Income Expense
$ -72.14M$ -113.33M$ 12.51M$ 12.27M$ 123.44M-
Pretax Income
$ -234.16M$ -520.12M$ -445.72M$ -386.21M$ -308.29M$ -130.35M
Tax Provision
$ 157.00K$ -1.86M$ 625.00K$ -3.61M$ -41.91M$ -2.60M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -234.31M$ -518.25M$ -446.35M$ -403.58M$ -266.37M$ -127.74M
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 248.09M$ 724.63M$ 572.63M$ 369.42M$ 259.52M-
Net Income From Continuing And Discontinued Operation
$ -234.31M$ -518.25M$ -446.35M$ -403.58M$ -266.37M$ -127.74M
Normalized Income
$ -153.69M-----
Interest Expense
$ 1.64M-----
EBIT
$ -191.43M-$ -434.93M$ -406.30M$ -308.09M-
EBITDA
$ -191.43M-$ -416.54M$ -392.38M$ -298.16M-
Currency in USD

Legend Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis